To evaluate the prognostic value of the tumor dissemination characteristic, metabolic parameters from baseline 18F-FDG PET/CT, clinical indicators, and pathological indicators in small cell lung cancer (SCLC), and to construct prognostic models.

Read the full article on ejradiology.com